Oral BG-12 in multiple sclerosis

N Engl J Med. 2013 Apr 25;368(17):1652. doi: 10.1056/NEJMc1212740.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Female
  • Fumarates / therapeutic use*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*
  • Peptides / therapeutic use*

Substances

  • Fumarates
  • Immunosuppressive Agents
  • Peptides